Multiple Sclerosis Trial, Recruiting (NCT06805318)

Multiple Sclerosis Trial, Recruiting NCT06805318 Sponsor: Fondazione Italiana Sclerosi Multipla Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT06805318 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a confirmed diagnosis of multiple sclerosis (MS)
People who are 18 years of age or older
People who are currently employed at the time of joining the study
People who have worked at least one day in the past 12 months
People whose MS-related work difficulties score at least 15 on a specific questionnaire called the MSQ-Job (confirm with trial site)
People who have provided written agreement to participate in the study

Who may not be able to join:

People who have other health conditions that affect their ability to work productively

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giampaolo Brichetto, PhD, Fondazione Italiana Sclerosi Multipla

Phone: +39 0102713246

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06805318

Sponsor: Fondazione Italiana Sclerosi Multipla

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +39 0102713246

More information: https://clinicaltrials.gov/study/NCT06805318

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a confirmed diagnosis of multiple sclerosis (MS)
People who are 18 years of age or older
People who are currently employed at the time of joining the study
People who have worked at least one day in the past 12 months
People whose MS-related work difficulties score at least 15 on a specific questionnaire called the MSQ-Job (confirm with trial site)
People who have provided written agreement to participate in the study

Who may not be able to join:

People who have other health conditions that affect their ability to work productively

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fondazione Italiana Sclerosi Multipla

Registry

ClinicalTrials.gov

Start date

15 January 2025

Est. completion

31 October 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Interception; Acceptance; Adherence; Lost to Follow-Up; Canadian Occupational Performance Measure (COPM); Client Satisfaction Questionnaire (CSQ); Global Perceived Effect (GPE) scale; Barthel Index (BI); Hospital Anxiety Depression scale (HADS); Modified Fatigue (MFIS-21); Multiple Sclerosis Neuropsychological Questionnaire for patient (MSNQ-p); WHO Disability Assessment Schedule (WHODAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov